|
US5840307A
(en)
*
|
1995-03-31 |
1998-11-24 |
Immulogic Pharmacuetical Corp. |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
|
|
US20020032316A1
(en)
*
|
1995-03-31 |
2002-03-14 |
Cantab Pharmaceuticals Research Limited |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
US5876727A
(en)
*
|
1995-03-31 |
1999-03-02 |
Immulogic Pharmaceutical Corporation |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
AU719289B2
(en)
|
1995-12-14 |
2000-05-04 |
Scripps Research Institute, The |
Anti-cocaine vaccine
|
|
US5817770A
(en)
|
1997-03-21 |
1998-10-06 |
Drug Abuse Sciences, Inc. |
Cocaethylene immunogens and antibodies
|
|
EP1015028A2
(en)
*
|
1997-09-19 |
2000-07-05 |
Serex, Inc. |
Methods to improve immunogenicity of antigens and specificity of antibodies
|
|
SE9801923D0
(sv)
*
|
1998-05-29 |
1998-05-29 |
Independent Pharmaceutical Ab |
Nicotine vaccine
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US6858211B1
(en)
*
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
US6232082B1
(en)
*
|
1998-12-01 |
2001-05-15 |
Nabi |
Hapten-carrier conjugates for treating and preventing nicotine addiction
|
|
GB2361473C
(en)
*
|
2000-03-08 |
2005-06-28 |
Microgenics Corp |
Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
|
|
GB0031079D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Vaccine
|
|
AU2002251821A1
(en)
*
|
2001-01-26 |
2002-08-06 |
The Scripps Research Institute |
Nicotine immunogens and antibodies and uses thereof
|
|
NZ511705A
(en)
*
|
2001-05-14 |
2004-03-26 |
Horticulture & Food Res Inst |
Methods and rapid immunoassay device for detecting progesterone and other steroids
|
|
DE60219630T2
(de)
*
|
2001-06-15 |
2007-12-27 |
Vicuron Pharmaceuticals, Inc., Fremont |
Bicyclische pyrrolidinverbindungen
|
|
US7115266B2
(en)
*
|
2001-10-05 |
2006-10-03 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
|
BR0213117A
(pt)
|
2001-10-05 |
2004-09-21 |
Cytos Biotechnology Ag |
Conjugados peptìdeo angiotensina-veìculo e seus usos
|
|
WO2003082329A2
(en)
*
|
2002-03-01 |
2003-10-09 |
The Board Of Regents Of The University Of Nebraska |
Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
|
|
EP2392345A3
(en)
*
|
2002-07-18 |
2012-03-07 |
Cytos Biotechnology AG |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
EP1685138B1
(en)
*
|
2003-11-17 |
2009-10-14 |
North Carolina State University |
Regiospecific synthesis of nicotine derivatives
|
|
US7279340B2
(en)
*
|
2004-04-07 |
2007-10-09 |
Dade Behring Inc. |
Synthesis and application of procainamide analogs for use in an immunoassay
|
|
MXPA04006617A
(es)
|
2004-07-07 |
2006-01-12 |
Inst Nac De Psiquiatria Ramon |
Proceso para la preparacion y uso de una vacuna bivalente contra la adiccion a la morfina-heroina.
|
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
FR2877668B1
(fr)
*
|
2004-11-10 |
2007-07-06 |
Gemac Sa |
Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
WO2008105773A2
(en)
*
|
2006-03-31 |
2008-09-04 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
|
JP5630998B2
(ja)
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
機能的粒子のためのポリマー
|
|
US20110052697A1
(en)
*
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
WO2007150030A2
(en)
*
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
US20100144845A1
(en)
*
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
WO2008147456A2
(en)
*
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
WO2008124639A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Poly (amino acid) targeting moieties
|
|
BRPI0817664A2
(pt)
|
2007-10-12 |
2015-03-24 |
Massachusetts Inst Technology |
Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
|
|
WO2009149252A1
(en)
*
|
2008-06-04 |
2009-12-10 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
US20110182918A1
(en)
|
2008-06-13 |
2011-07-28 |
Nabi Biopharmaceuticals |
Personalized drug treatment and smoking cessation kit and method
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
RU2011140858A
(ru)
|
2009-03-09 |
2013-04-20 |
Уилльям ХЕНРИ |
Конъюгаты гаптен-носитель, содержащие в качестве носителя бактериальные токсины, обладающие сигнальным пептидом, и их применение в иммуногенных композициях
|
|
CA2759332A1
(en)
*
|
2009-04-21 |
2010-10-28 |
Selecta Biosciences, Inc. |
Immunonanotherapeutics providing a th1-biased response
|
|
AR077611A1
(es)
|
2009-07-31 |
2011-09-07 |
Nabi Biopharmaceuticals |
Metodo y conjunto de elementos ( kit) para tratar la adiccion a la nicotina. combinacion. uso.
|
|
US20120225087A1
(en)
*
|
2009-09-14 |
2012-09-06 |
The Scripps Research Institute |
Nicotine haptens, immunoconjugates and their uses
|
|
CN102892429B
(zh)
|
2010-03-17 |
2016-08-31 |
康奈尔大学 |
基于被破坏的腺病毒的抗滥用药物疫苗
|
|
WO2011123042A1
(en)
*
|
2010-04-01 |
2011-10-06 |
Independent Pharmaceutica Ab |
Vaccination procedure and products for use therein
|
|
GB201006324D0
(en)
|
2010-04-15 |
2010-06-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US20110293700A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Nanocarrier compositions with uncoupled adjuvant
|
|
TWI578997B
(zh)
*
|
2010-06-04 |
2017-04-21 |
輝瑞疫苗有限責任公司 |
用於預防或治療菸鹼成癮之共軛體
|
|
EP2640190A4
(en)
|
2010-11-05 |
2016-05-11 |
Selecta Biosciences Inc |
MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
|
|
CN109172819A
(zh)
|
2011-07-29 |
2019-01-11 |
西莱克塔生物科技公司 |
产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
|
|
EP2568289A3
(en)
|
2011-09-12 |
2013-04-03 |
International AIDS Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
WO2013154744A1
(en)
|
2012-04-13 |
2013-10-17 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
|
ES2927758T3
(es)
*
|
2013-03-14 |
2022-11-10 |
Alere San Diego Inc |
Análogos de 6-acetilmorfina y procedimientos para su síntesis y uso
|
|
WO2015179403A1
(en)
|
2014-05-19 |
2015-11-26 |
The Scripps Research Institute |
Enantiopure haptens for nicotine vaccine development
|
|
WO2018080838A1
(en)
*
|
2016-10-24 |
2018-05-03 |
The Scripps Research Institute |
Anti-opioid vaccines
|
|
CA3066915A1
(en)
*
|
2017-06-11 |
2018-12-20 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
|
CN108409749B
(zh)
*
|
2018-01-30 |
2019-09-06 |
中国农业科学院蜜蜂研究所 |
钩吻素己半抗原和全抗原及其制备方法与应用
|
|
US12455283B2
(en)
*
|
2019-01-29 |
2025-10-28 |
Teknologian Tutkimuskeskus Vtt Oy |
Methods for screening polypeptides capable of binding specific target molecules and tools related thereto
|
|
CN113999163A
(zh)
*
|
2021-11-03 |
2022-02-01 |
公安部第三研究所 |
合成大麻素半抗原化合物及其制备方法和用途
|
|
CN115974836A
(zh)
*
|
2023-01-16 |
2023-04-18 |
浙江安诺和生物医药有限公司 |
一种s-(-)-6-甲基尼古丁水杨酸盐及其制备方法
|
|
WO2024238822A1
(en)
*
|
2023-05-17 |
2024-11-21 |
Regents Of The University Of Minnesota |
Heroin vaccine compositions and methods thereof
|
|
CN117865868B
(zh)
*
|
2023-05-19 |
2024-09-06 |
湖南大学 |
一种功能化分子、其制备方法及其应用
|